Clinical trial
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
NCT06772363
Study timeline
Study start (estimated)2026-04-09Date precision: day
Registry last updated2025-03-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancersunresolved
Interventions
Serum Raman spectroscopy intelligent diagnostic systemDIAGNOSTIC_TEST
Sponsors & collaborators
Fuzhou General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06772363 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.